Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCNA | P12004 | 3/20 | 0.66 |
| ▸ | THRB | P10828 | 10/20 | 0.56 |
| ▸ | THRA | P10827 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | GABRP | O00591 | 1/20 | 0.56 |
| ▸ | GABRD | O14764 | 1/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30693721 | 1.00 | PCNA (0.66) | PCNATHRBTHRAMEN1KMT2A | |
| Carbamic Acid SCHEMBL7215408 | 0.97 | PCNA (0.63) | PCNATHRBTHRAMEN1KMT2A | |
| Alcohol SCHEMBL5573250 | 0.95 | PCNA (0.60) | PCNATHRBTHRAMEN1KMT2A | |
| Sulfuric Acid SCHEMBL8910589 | 0.95 | PCNA (0.60) | PCNATHRBTHRAMEN1KMT2A | |
| SCHEMBL10938099 | 0.87 | KMT2A (0.61) | PCNATHRBTHRAMEN1KMT2A | |
| SCHEMBL836727 | 0.87 | KMT2A (0.61) | PCNATHRBTHRAMEN1KMT2A | |
| SCHEMBL4355962 | 0.87 | KMT2A (0.61) | PCNATHRBTHRAMEN1KMT2A | |
| Thyroxine SCHEMBL10886155 | 0.87 | PCNA (0.77) | PCNATHRBTHRAMEN1KMT2A | |
| SCHEMBL10880452 | 0.84 | SCN9A (0.48) | PCNATHRBTHRAMEN1KMT2A | |
| SCHEMBL1572565 | 0.84 | KDM4E (0.56) | PCNATHRBTHRAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101963-A1 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-03-28 | — | — | US | claimed |
| CN-114540303-A | Limbal stem cell culture solution and preparation method thereof | 赛尔生命科技(深圳)有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | claimed |
| EP-3775180-B1 | BIOSENSOR FOR DIAGNOSIS OF THYROID DYSFUNCTION | AEGIRBIO AB (SE) | 2022-01-12 | — | — | EP | claimed |
| US-20210215723-A1 | Biosensor for Diagnosis of Thyroid Dysfunction | AEGIRBIO AB (SE) | 2021-07-15 | — | — | US | claimed |
| WO-2021102352-A1 | TUMOR ORGANOID CULTURE COMPOSITIONS, SYSTEMS, AND METHODS | TEMPUS LABS, INC. (US) | 2021-05-27 | — | — | WO | claimed |
| CN-112437812-A | Biosensor for diagnosing thyroid gland dysfunction | 埃吉尔比奥公司 | 2021-03-02 | — | — | CN | claimed |
| US-10927412-B2 | Endometriosis classifier | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-23 | — | — | US | claimed |
| EP-3775180-A1 | BIOSENSOR FOR DIAGNOSIS OF THYROID DYSFUNCTION | Aegirbio AB (SE) | 2021-02-17 | — | — | EP | claimed |
| CN-111989041-A | Vaginal measurements using vaginal rings | 里加利私人有限公司 | 2020-11-24 | — | — | CN | claimed |
| US-4399121-A | Iodothyronine immunogens and antibodies | MILES LABORATORIES, INC. (US) | 1983-08-16 | — | — | US | claimed |
| EP-0079489-A1 | Methotrexate-labeled iodothyronine conjugates and method, reagent means and test device for the determination of iodothyronine in or iodothyronine uptake of a liquid sample | MILES LABORATORIES, INC. (US) | 1983-05-25 | — | — | EP | claimed |
| EP-0078952-A1 | N-aminoalkyl iodothyronine derivatives, iodothyronine immunogens and antibodies | MILES LABORATORIES, INC. (US) | 1983-05-18 | — | — | EP | claimed |
| EP-0078477-A2 | Fenclofenac as TBP blocking agent in iodothyronine immunoassays | MILES LABORATORIES, INC. (US) | 1983-05-11 | — | — | EP | claimed |
| EP-0073865-A1 | Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds | AMERSHAM INTERNATIONAL plc (GB) | 1983-03-16 | — | — | EP | claimed |
| US-4376165-A | Method of preparing an enzyme-labeled ligand for use in specific binding assays and the labeled conjugate produced thereby | MILES LABORATORIES, INC. (US) | 1983-03-08 | — | — | US | claimed |
| US-4358604-A | ANTIBODIES-USEFUL IN IMMUNOASSAY | MILES LABORATORIES, INC. (US) | 1982-11-09 | — | — | US | claimed |
| US-4331808-A | Chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labeled haptens | MILES LABORATORIES, INC. (US) | 1982-05-25 | — | — | US | claimed |
| US-4238565-A | Specific binding assay with a prosthetic group as a label component | MILES LABORATORIES, INC. (US) | 1980-12-09 | — | — | US | claimed |
| US-4213893-A | Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays | MILES LABORATORIES, INC. (US) | 1980-07-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101963-A1 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | IAPP, ALPG, PNLIP | PCNA 4136/4885THRB 1174/4885THRA 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.